According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -$5.69. In 2022 the company made an earnings per share (EPS) of -$4.25 a decrease over its 2021 EPS that were of -$2.83.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.69 | 33.88% |
2022 | -$4.25 | 50.18% |
2021 | -$2.83 | 40.8% |
2020 | -$2.01 | -4.74% |
2019 | -$2.11 | 8.21% |
2018 | -$1.95 | -24.12% |
2017 | -$2.57 | -776.32% |
2016 | $0.38 | -139.18% |
2015 | -$0.97 | 125.58% |
2014 | -$0.43 | -67.67% |
2013 | -$1.33 | -44.58% |
2012 | -$2.40 | -44.95% |
2011 | -$4.36 | -6.84% |
2010 | -$4.68 | -290.24% |
2009 | $2.46 | -135.96% |
2008 | -$6.84 | 10.68% |
2007 | -$6.18 | -33.97% |
2006 | -$9.36 | 5.41% |
2005 | -$8.88 | -60.64% |
2004 | -$22.56 | -77.21% |
2003 | -$99.00 |